ImmunityBio, Inc. IBRX
At closeNov 11, 2026, 7:48 PM EST
After hours · Nov 11, 7:48 PM ET
- YTD
- +236.87%
- 1 year
- +211.68%
Discussion (3500)
Sign in to join the discussion
The reason IBRX runs into the close is this simple. Day trading penny flippers don't want to be out after market and premarket just in case news drops and the stock pops $2-$5 in minutes
Tony get off the board. No one gives a crap about you political opinions.
🖕👿👍👿please ☠️
Same BS day trading fools can't wait to see the huge pop and you fools have sold out for nicked dimes and quarters
So sick of the day trading penny flipping morons
PDSB
I am looking at this. It's a spec but it's looking good
They have complete 4 phase 2 studies and have 4 more going 8 in total, for multiple cancers. It involves T cells so it is a great match for Anktiva and the IA robotic lab T cells NK cells.
Will do more on it tomorrow. Dr PSS has seen all of the trial results and he must like what he sees so he invested.
Going from here to a FDA approval could easily be years. But ImmunityBio is marketing to the world and if these immunotherapies pan out they could market to the world too.
It could easily be bought out by ImmunityBio or someone else in the future.
PDSB
I may buy like 25,000 shares it's .45 a share
Dr PSS investing and he is now on their board are huge positives.
Short squeeze ready for launch
